+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Symbyax"

US Depression Drugs Market, Dosage, Price, Sales Insight 2021-2026 - Product Thumbnail Image

US Depression Drugs Market, Dosage, Price, Sales Insight 2021-2026

  • Report
  • February 2021
  • 420 Pages
  • United States
From
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Symbyax is a medication used to treat mental disorders such as depression and bipolar disorder. It is a combination of olanzapine, an antipsychotic, and fluoxetine, an antidepressant. The medication works by blocking certain receptors in the brain that are associated with mental illness. It is used to treat both the depressive and manic episodes of bipolar disorder. It is also used to treat major depressive disorder when other treatments have failed. Symbyax is available in both generic and brand-name forms. It is typically taken once daily, with or without food. Common side effects include weight gain, drowsiness, and dry mouth. The Symbyax market is composed of pharmaceutical companies that manufacture and distribute the medication. These companies include Eli Lilly, Pfizer, and Mylan. They are responsible for the research, development, and marketing of the drug. They also provide information about the medication to healthcare professionals and patients. Show Less Read more